Ultraviolet-A (UVA-1) radiation suppresses immunoglobulin production of activated B lymphocytes in vitro

Clinical and Experimental Immunology

Volumn 145, Issue 3, 2006, Pages 528-534

  Polderman, M C A ^a   Van Kooten, C ^a   Smit, N P M ^a   Kamerling, S W A ^a   Pavel, S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B cells; Immunoglobulins; Skin; SLE; UV radiation

Indexed keywords

CATALASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 4;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ACTIVITY; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RADIATION DOSE; SKIN CAPILLARY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; ULTRAVIOLET A RADIATION; WHOLE BODY RADIATION;

B-LYMPHOCYTES; CATALASE; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-10; INTERLEUKIN-4; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MONOCYTES; SKIN; T-LYMPHOCYTES; TISSUE CULTURE TECHNIQUES; ULTRAVIOLET RAYS;

EID: 33645544923     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03136.x     Document Type: Article

References (22)

1. Grammer AC, Lipsky PE. CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus. Arthritis Rheum 2002; 46:1417-29.
2. Gescuk BD, Davis JC Jr. Novel therapeutic agents for systemic lupus erythematosus. Curr Opin Rheumatol 2002; 14:515-21.
3. Wallace DJ. Management of lupus erythematosus: recent insights. Curr Opin Rheumatol 2002; 14:212-19.
4. McGrath H, Martinez-Osuna P, Lee FA. Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus. Lupus 1996; 5:269-74.
5. McGrath H Jr. Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1994; 12:129-35.
6. Molina JF, McGrath H Jr. Longterm ultraviolet-A1 irradiation therapy in systemic lupus erythematosus. J Rheumatol 1997; 24:1072-4.
7. McGrath H, Bell JR, Haynes MR, Martinez-Osuna P. Ultraviolet-A irradiation therapy for patients with systemic lupus erythematosus: a pilot study. Cur Ther Res 1994; 55:373-81.
8. McGrath H Jr, Bak E, Michalski JP. Ultraviolet-A light prolongs survival and improves immune function in (New Zealand black x New Zealand white) F1 hybrid mice. Arthritis Rheum 1987; 30:557-61.
9. Polderman MC, Huizinga TW, Le Cessie S, Pavel S. UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial. Ann Rheum Dis 2001; 60:112-5.
10. Polderman MC, Le Cessie S, Huizinga TW, Pavel S. Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology (Oxf), 2004; 43:1402-4.
11. Boehringer Product Catalogue, Mannheim, Germany. Overnight incubation with dispase grade II (295825). 2005.
12. Brouwers JF, Gadella BM. In situ detection and localization of lipid peroxidation in individual bovine sperm cells. Free Radic Biol Med 2003; 35:1382-91.
13. Banchereau J, Bazan F, Blanchard D et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12:881-922.
14. de Fijter JW, van Nisselrooij NI, Schroeijers WE, Daha MR, Van Es LA, Van Kooten C. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy. Nephrol Dial Transplant 1998; 13:285-92.
15. van Ree R, Van Leeuwen WA, Dieges PH et al. Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy. Clin Exp Allergy 1997; 27:68-74.
16. Rousset F, Garcia E, Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 1991; 173:705-10.
17. Rousset F, Garcia E, Defrance T et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89:1890-3.
18. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 1999; 112:3-12.
19. Godar DE, Miller SA, Thomas DP. Immediate and delayed apoptotic cell death mechanisms. UVA versus UVB UVC irradiation. Cell Death Differ 1994; 1:59-66.
20. Farber CM, Liebes LF, Kanganis DN, Silber R. Human B lymphocytes show greater susceptibility to H2O2 toxicity than T lymphocytes. J Immunol 1984; 132:2543-6.
21. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig) M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998; 188:1679-89.
22. Jacobi AM, Odendahl M, Reiter K et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2003; 48:1332-42.